Neurogene (NGNE)
NASDAQ:NGNE
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 30, 2026 | xxxxxxxxxxxxx | $73979 | |
Mar 30, 2026 | xxxxxxxxxxxxx | $55304 | |
Mar 30, 2026 | xxxxxxxxxxxxx | $18125 | |
Mar 17, 2026 | xxxxxxxxxxxxx | $84161 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,347,659 | Insider | 8.70% | 28,408,652 | |
| 991,691 | Institution | 6.40% | 20,904,846 | |
| 554,438 | Institution | 3.58% | 11,687,553 | |
| 479,380 | Institution | 3.09% | 10,105,330 | |
| 454,769 | Institution | 2.94% | 9,586,531 | |
| 446,880 | Institution | 2.88% | 9,420,230 | |
| 208,377 | Institution | 1.35% | 4,392,587 | |
| 134,485 | Institution | 0.87% | 2,834,944 | |
| 117,103 | Institution | 0.76% | 2,468,531 | |
| 113,674 | Institution | 0.73% | 2,396,248 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 479,380 | Institution | 3.09% | 10,105,330 | |
| 134,485 | Institution | 0.87% | 2,834,944 | |
| 113,674 | Institution | 0.73% | 2,396,248 | |
| 113,400 | Institution | 0.73% | 2,390,472 | |
| 101,093 | Institution | 0.65% | 2,131,040 | |
| 55,211 | Institution | 0.36% | 1,163,848 | |
| 51,100 | Institution | 0.33% | 1,077,188 | |
| 29,959 | Institution | 0.19% | 631,536 | |
| 21,093 | Institution | 0.14% | 444,640 | |
| 11,190 | Institution | 0.07% | 235,885 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 382,191 | Institution | 2.47% | 6,749,493 | |
| 234,639 | Institution | 1.51% | 4,946,190 | |
| 115,861 | Institution | 0.75% | 2,046,105 | |
| 101,725 | Institution | 0.66% | 2,194,208 | |
| 94,302 | Institution | 0.61% | 1,987,886 | |
| 82,545 | Institution | 0.53% | 1,740,049 | |
| 77,276 | Institution | 0.50% | 1,666,843 | |
| 56,082 | Institution | 0.36% | 1,209,689 | |
| 56,082 | Institution | 0.36% | 1,209,689 | |
| 56,082 | Institution | 0.36% | 1,209,689 |
FAQ
Who Owns Neurogene (NGNE)?
Currently, no data Available
What percentage of Neurogene (NGNE) stock is held by institutional investors?
Currently, no data Available
What percentage of Neurogene (NGNE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Neurogene (NGNE)?
Rachel Mcminn owns the most shares of Neurogene (NGNE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.